Flow Traders U.S.’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,467
Closed -$509K 1078
2025
Q4
$509K Sell
2,467
-636
-20% -$127K 0.02% 563
2025
Q3
$556K Buy
3,103
+196
+7% +$33.4K 0.02% 584
2025
Q2
$469K Buy
+2,907
New +$463K 0.02% 630
2024
Q3
Sell
-5,046
Closed -$777K 955
2024
Q2
$777K Buy
5,046
+1,583
+46% +$238K 0.04% 422
2024
Q1
$533K Sell
3,463
-145
-4% -$22.1K 0.03% 456
2023
Q4
$570K Buy
3,608
+2,138
+145% +$307K 0.02% 476
2023
Q3
$215K Buy
+1,470
New +$224K 0.01% 698
2023
Q2
Sell
-5,785
Closed -$897K 935
2023
Q1
$897K Buy
5,785
+2,245
+63% +$353K 0.04% 350
2022
Q4
$546K Buy
+3,540
New +$522K 0.03% 424
2022
Q2
Sell
-6,136
Closed -$915K 865
2022
Q1
$915K Sell
6,136
-3,131
-34% -$463K 0.03% 392
2021
Q4
$1.5M Sell
9,267
-2,980
-24% -$482K 0.08% 200
2021
Q3
$2.03M Sell
12,247
-14,783
-55% -$2.53M 0.08% 267
2021
Q2
$4.67M Buy
27,030
+23,334
+631% +$3.85M 0.23% 91
2021
Q1
$593K Sell
3,696
-9,999
-73% -$1.71M 0.03% 459
2020
Q4
$2.3M Buy
13,695
+7,874
+135% +$1.28M 0.16% 125
2020
Q3
$915K Buy
+5,821
New +$952K 0.07% 235

Other funds holding FBT

Flow Traders U.S.'s FBT Position: Q1 2026 in Review

Flow Traders U.S. sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2026, closing a stake of 2,467 shares — an estimated $509K sold.

Flow Traders U.S. first reported a position in FBT in Q3 2020 and held it in 16 quarters. The position peaked at $4.67M in Q2 2021. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Flow Traders U.S. reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2026 after selling out during the quarter.
  • Flow Traders U.S. sold 2,467 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $509K.
  • Flow Traders U.S. first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2020 and held it in 16 quarters.
  • Flow Traders U.S.'s First Trust NYSE Arca Biotechnology Index Fund position peaked at $4.67M in Q2 2021.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Flow Traders U.S.'s 13F filing for Q1 2026, filed 15 May 2026.